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Membrane Localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA)
Produced by Aggregatibacter Actinomycetemcomitans
Abstract
The oral bacterium, Aggregatibacter actinomycetemcomitans, which is associated with localized
aggressive periodontitis, as well as systemic infections including endocarditis, produces numerous
virulence factors, including a repeats-in-toxin (RTX) protein called leukotoxin (LtxA), which kills human
immune cells. The strains of A. actinomycetemcomitans most closely associated with disease have been
shown to produce the most LtxA, suggesting that LtxA plays a significant role in the virulence of this
organism. LtxA, like many of the RTX toxins, can be divided into four functional domains: an N-terminal
hydrophobic domain, which contains a significant fraction of hydrophobic residues and has been
proposed to play a role in the membrane interaction of the toxin; the central domain, which contains two
lysine residues that are the sites of post-translational acylation; the repeat domain that is characteristic of
the RTX toxins, and a C-terminal domain thought to be involved in secretion. In its initial interaction with
the host cell, LtxA must bind to both cholesterol and an integrin receptor, lymphocyte function-associated
antigen-1 (LFA-1). While both interactions are essential for toxicity, the domains of LtxA involved remain
unknown. We therefore undertook a series of experiments, including tryptophan quenching and trypsin
digestion, to characterize the structure of LtxA upon interaction with membranes of various lipid
compositions. Our results demonstrate that LtxA adopts a U-shaped conformation in the membrane, with
the N- and C-terminal domains residing outside of the membrane. © 2018 Brown et al. This is an open
access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited.
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The oral bacterium, Aggregatibacter actinomycetemcomitans, which is associated with
localized aggressive periodontitis, as well as systemic infections including endocarditis, produces numerous virulence factors, including a repeats-in-toxin (RTX) protein called leukotoxin (LtxA), which kills human immune cells. The strains of A. actinomycetemcomitans
most closely associated with disease have been shown to produce the most LtxA, suggesting that LtxA plays a significant role in the virulence of this organism. LtxA, like many of the
RTX toxins, can be divided into four functional domains: an N-terminal hydrophobic domain,
which contains a significant fraction of hydrophobic residues and has been proposed to play
a role in the membrane interaction of the toxin; the central domain, which contains two lysine
residues that are the sites of post-translational acylation; the repeat domain that is characteristic of the RTX toxins, and a C-terminal domain thought to be involved in secretion. In its
initial interaction with the host cell, LtxA must bind to both cholesterol and an integrin receptor, lymphocyte function-associated antigen-1 (LFA-1). While both interactions are essential
for toxicity, the domains of LtxA involved remain unknown. We therefore undertook a series
of experiments, including tryptophan quenching and trypsin digestion, to characterize the
structure of LtxA upon interaction with membranes of various lipid compositions. Our results
demonstrate that LtxA adopts a U-shaped conformation in the membrane, with the N- and
C-terminal domains residing outside of the membrane.
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Introduction
Aggregatibacter actinomycetemcomitans is a facultative anaerobic bacterium commonly found
in the upper aerodigestive tract of man and certain higher primates [1]. The organism produces a 114-kDa RTX (Repeats in ToXin) toxin [2] or leukotoxin (LtxA) that expresses a specificity that is unique to human immune cells [3–5].
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The RTX toxins are a family of large, bacterial proteins with diverse biological functions
that are produced by an ever increasing number of Gram-negative bacteria [2]. This family of
toxins possesses a number of similarities, including sequence and structural homology, which
has allowed us to divide LtxA into four functional domains (Fig 1) for our studies. The hydrophobic domain (residues 1–420) contains most of the hydrophobic amino acid residues found
in LtxA [6] and because of this, this region has historically been proposed to engage the membrane in some manner [7]. The central domain (residues 421–730) contains two lysine residues, K562 and K687, that are the sites of the post-translational acylation [8]. The repeat region
(residues 731–900) contains fourteen nonapeptide, glycine-rich repeated amino acid
sequences, which fold into a β-roll conformation in the presence of calcium [9–12]. Finally,
the C-terminal domain (residues 901–1055) has been suggested to be involved in secretion
[13].
RTX toxins also share a mechanism of secretion which utilizes the type 1 secretion system
(T1SS) [2], an oligomeric channel that spans the bacterial cell envelope and enables single-step
translocation of RTX polypeptides from the bacterial cytosol across both the inner and the
outer bacterial membrane, directly into the extracellular space without involvement of periplasmic secretion intermediates [15–17]. The ability of the toxin to be secreted via the T1SS is
regulated by the calcium-binding activity of the repeat domain [18]. In the bacterial cytoplasm,
the concentration of Ca2+ ions is typically low (<100 nM) [19] allowing for maintenance of an
RTX repeat region that is flexible and amenable to T1SS-mediated secretion. Once in the extracellular space that is colonized by the oral microflora, millimolar calcium concentrations are
typically encountered [20], which results in loading of the RTX repeat domain of the secreted
protein by Ca2+ ions [21, 22], completion of tertiary folding [10, 23], and acquisition of biological activity [18].
Once secreted into the external environment, LtxA travels in a water-soluble form through
this milieu before recognizing and binding to white blood cells. The recognition of its human
host by LtxA is multifaceted and involves both the membrane lipids [24, 25] and a cell-surface
glycoprotein, lymphocyte function-associated antigen-1 (LFA-1), a β2 integrin family member
[26]. The cell specificity of LtxA derives from its association with LFA-1 [26, 27], which is
uniquely expressed on the plasma membranes of immune cells [26]. While the interaction of
LtxA with LFA-1 is essential for activity of the toxin, LtxA also requires the presence of

Fig 1. Four functional domains of LtxA. The hydrophobic domain (residues 1–420, red) contains most of the hydrophobic amino acid residues of LtxA. The central
domain (residues 421–730, green) contains two internal lysine residues (K562 and K687, bars, K) that are the sites of post-translational acylation. The repeat domain
(residues 731–900, blue) contains the characteristic repeated amino acid sequence of the RTX family. The C-terminal domain (residues 901–1055, orange) is
hypothesized to play a role in secretion. A cholesterol binding site (CRAC336, yellow square, C) is located in the hydrophobic domain. Five tryptophan residues (blue
circles, W) are located throughout the sequence of LtxA at residues 115, 430, 478, 577, and 901. The three monoclonal antibody epitopes are marked with green bars;
mAb 28 recognizes residues 698–709, mAb 83 recognizes residues 746–757, and mAb 107 recognizes residues 926–937 [14].
https://doi.org/10.1371/journal.pone.0205871.g001
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cholesterol in the host plasma membrane, a recognition process that is mediated by the presence of a cholesterol recognition amino acid consensus (CRAC) motif [24], which is defined
by the sequence -L/V–X1-5–Y–X1-5–R/K- [28, 29] and is located within the hydrophobic
domain of LtxA. The interaction of LtxA with LFA-1 and the plasma membrane lipids appears
to be linked, as the toxin’s binding to cholesterol initiates a signaling cascade that leads to the
clustering of LtxA and LFA-1 in large cholesterol-rich rafts [8]. Additionally, model membrane
experiments suggest that LtxA associates with immune cell membranes to form round, toxinrich patches and lipid-lined cavities through a process involving membrane bending [25]. Similar interactions have been observed for a number of RTX toxins, including Bordetella pertussis
adenylate cyclase toxin [30] and Mannheimia haemolytica leukotoxin [31].
LtxA epitopes on LFA-1 have been proposed to reside within β sheets 1 and 2 of the β-propeller of the αL subunit of LFA-1 [32, 33] and integrin-epidermal growth factor-like domains
2, 3, and 4 of the β2 subunit [34] of LFA-1. In addition, we have recently discovered that LtxA
binds to the cytosolic αL and β2 domains of LFA-1 [35], suggesting that LtxA may reside partially embedded in the membrane, allowing it to interact with both extracellular and intracellular domains of both subunits of LFA-1.
It appears that the interaction of the RTX toxins with the host cell plasma membrane is
shared among the various toxins; however since the molecular structure of an RTX protein has
not been solved, the specific domains of the toxins that interact with the membrane have not
been identified beyond our identification of the cholesterol-binding site [24]. The reasons for
this issue are not clear and could reside in the intrinsic disorder that is naturally present in the
nonapeptide repeats or the posttranslational modifications the protein undergoes prior to
secretion. Our goal in the current study was to use a variety of biophysical techniques, including tryptophan quenching, trypsin digestion, and mass spectrometry to determine the orientation of LtxA on the host cell plasma membrane to better understand the toxin’s membrane
and receptor interactions.

Materials and methods
LtxA purification
A. actinomycetemcomitans, strain JP2, was grown overnight in AAGM broth [36] and the
secreted toxin was purified following a published protocol [37]. The bacterial culture supernatant was precipitated with ammonium sulfate (32.5%, 4˚C, 2 h). The precipitate was recovered
by centrifugation (10,000 r.p.m., 20 min), suspended in phosphate buffer (10 mM KH2PO4,
pH 6.5), and dialyzed overnight in phosphate buffer. The supernatant was then filtered and
applied to a HiTRAP SP column (GE Healthcare, Piscataway, NJ, USA). LtxA was eluted with
a buffer containing 0.6 M NaCl in 10 mM KH2PO4, pH 6.5. The toxin was lyophilized and
stored at -80˚C. The purity of LtxA was confirmed by SDS-PAGE, the identity by Western
blot, and the activity with a cytotoxicity assay [37] (S1 Fig).

Cell culture
The T lymphocyte cell line, Jn.9, a subclone of Jurkat cells [38], were maintained in RPMI
1640 medium containing 10% FBS, 0.1 mM MEM non-essential amino acids, 1x MEM vitamin solution, 2 mM L-glutamine, and 0.5 μg/mL gentamicin at 37 ˚C under 5% CO2.

Immunofluorescence
LtxA was labeled with DyLightTM 650 (LtxA-DY650) using DyLightTM Amine-Reactive dye
(Pierce) according to the manufacturer’s instructions. After labeling, the excess dye was
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washed using a ZebaTM Spin Desalting column (40k MWCO, ThermoFisherTM Scientific). For
LtxA and cell membrane interaction studies, 1 x 106 Jn.9 cells were incubated with 20 nM
LtxA-DY650 for 30 min at 37 ˚C in a 24-well plate. We selected the 20 nM concentration for
our experiments because it is a sub-maximal dose at which the effect of LtxA on Jn.9 cells is
pronounced and specific. The cells were washed with PBS, and the cell nuclei and plasma
membranes were labeled for 10 min with 1 μM Hoechst 33342 and 5 μg/mL Wheat Germ
Agglutinin AlexaFluorTM 488 conjugate (WGA-AF488, Invitrogen), respectively. The cells
were washed, fixed with 4% paraformaldehyde for 10 min, washed again, and mounted on coverslips. The samples were examined using a Nikon A1R laser scanning confocal microscope
with a 100x oil objective. Images were analyzed using Nikon’s Elements software, version 4.1.

Liposome preparation
The lipids used in this work, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-methyl (NmDOPE), were purchased from
Avanti Polar Lipids (Alabaster, AL), and the sterols, cholesterol and cholesterol sulfate (CS),
were purchased from Sigma-Aldrich (St. Louis, MO). Stock solutions of lipids dissolved in
chloroform were added to a glass vial in the required amounts. The chloroform was evaporated
under nitrogen, and any residual chloroform was removed under vacuum, resulting in a thin
lipid film on the glass surface. The lipid film was hydrated with buffer and the resulting liposomes were extruded through a 200-nm polycarbonate membrane. For the tryptophan
quenching experiments, the lipids were hydrated in a buffer containing 10 mM HEPES, 1 M
NaCl, 10 mM CaCl2, and 1 mM Na2S2O3, at a pH of 7.4. Liposomes used in the mass spectrometry (MS) experiment were hydrated in 50 mM NH4HCO3 at a pH of 8.0.

Tryptophan quenching
LtxA in solution or incubated with liposomes at a molar lipid-to-protein ratio (L:P) of 1000:1
was analyzed by fluorescence spectroscopy. A series of emission scans (300–400 nm) were collected, with an excitation wavelength of 280 nm and slit widths of 4 nm. The fluorescence
intensity of the tryptophan at a wavelength of 350 nm was recorded. This intensity represents
the intensity of all five Trp residues in LtxA. A baseline reading (Fo) was obtained, and then a
small volume (4 uL) of KI buffer (10 mM HEPES, 1 M KI, 10 mM CaCl2, 1 mM Na2S2O3) was
added, and the sample was incubated for one minute before the fluorescence intensity (F) was
recorded again. This process was repeated until the final KI concentration in the cuvette
reached 200 mM.
The change in tryptophan intensity with addition of KI was determined by plotting Fo/F as
a function of KI concentration, where Fo is the intensity of tryptophan before the addition of
KI and F is the tryptophan intensity after each addition of KI. The data were plotted on a
Stern-Volmer plot following the equation:
Fo
¼ 1 þ KSV ½Q�
F
where KSV is the Stern-Volmer constant, and [Q] is the concentration of quencher (I-). The
slope of each line represents KSV, which is a measure of quenching efficiency and thus, the solvent accessibility of the Trp residues.

Trypsin digest
First, LtxA was incubated with buffer or DMPC liposomes at a molar L:P of 1000:1 for 30
mins. Unbound toxin was separated from the liposomes by centrifugal filtration using a Pall
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300,000 molecular weight cut-off (MWCO) filter. The proteoliposome solution was added to a
Vivacon 500 30,000 MWCO filter and centrifuged at 13,500 x g for 10 min. Additional buffer
was added, and the centrifugation step was repeated twice. Next, the digest was initiated by
adding 50 uL of 0.04 ug/uL trypsin (enzyme-to-protein ratio of 1:50) to the filter unit, which
was then shaken for 1 min. The filter units were incubated in a water bath at 37 ˚C for 1 hr.
After the 1-hr digestion, the filter units were centrifuged at 14,000 x g for 10 min to separate
the digested peptides from the proteoliposome. Additional buffer was added, and the centrifugation step was repeated twice. Ten uL of 10% formic acid was added to the filtrate to stop the
trypsin digestion. The filtered material was analyzed by mass spectrometry to identify the peptides derived from the domains of LtxA that reside outside of the membrane.
The unfiltered material (liposomes and undigested toxin) was removed from the centrifugal
filter and run on a Novex NuPAGE 12% Bis-Tris gel with NuPAGE MES SDS Running Buffer
until completion. A BenchMark Pre-Stained Protein Ladder was used to determine the molecular weight of the peptides. The major bands were excised, digested with trypsin, and analyzed
by mass spectrometry to identify the peptides derived from the domains of LtxA residing
within the liposome.

Mass spectrometry
LC-MS/MS analyses were performed at the Wistar Proteomics and Metabolomics Facility
(Philadelphia). Trypsin digestions were loaded into a UPLC Symmetry trap column (180 μm i.
d. × 2 cm packed with 5 μm C18 resin; Waters), and separations were performed on a 15-cm
PicoFrit column (75 μm inner diameter, New Objective) packed with Magic 5 μm C18
reversed-phase resin (Michrom Bioresources) using a nanoflow high-pressure LC system
(Eksigent Technologies), which was coupled online to a hybrid LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source. Chromatography was
performed with Solvent A (Milli-Q water with 0.1% formic acid) and Solvent B (acetonitrile
with 0.1% formic acid). Peptides were eluted at 200 nL/min for 3–28% B over 40 min, 28–50%
B over 25.5 min, 50–80% B over 5 min, hold at 80% B for 4.5 min before returning to 3% B
over 1 min. To minimize sample carryover, a short blank gradient was run between each sample. The LTQ-Orbitrap XL was operated in the data-dependent mode to automatically switch
between full scan MS (m/z 300–2000) in the Orbitrap analyzer (with resolution of 60,000 at m/
z 400) and the fragmentation of the six most intense ions by collision-induced dissociation in
the ion trap mass analyzer.
MS/MS spectra were extracted and searched using the SEQUEST algorithm in BioWorks
(version 3.3, Thermo Fisher Scientific) against a custom database containing the LtxA protein
sequence, combined with a reverse database and a list of common contaminants. MS/MS spectra were searched using partial trypsin specificity with up to two missed cleavages, a 100 ppm
precursor mass tolerance, 1 amu fragment ion mass tolerance, static modification of cys by
carbamidomethylation (+57.0215), and variable modifications for methionine oxidation (+15.9949) and asparagine deamidation (+0.9840). Consensus protein lists were generated by
DTASelect (version 2.0, Scripps Research Institute, La Jolla, CA).

Dot blot
For dot blot analysis, the LtxA digestion was performed in a similar manner as in the MS
experiment, but the resulting digested peptides were analyzed by immunoblotting rather than
MS. First, LtxA was incubated with trypsin to digest the entire protein. Two uL of this peptide
solution, representing peptides derived from the entire LtxA molecule, was spotted onto three
separate nitrocellulose membranes (top dot). Next, LtxA was incubated with DMPC, the
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unbound protein was removed, and the proteoliposomes were incubated with trypsin to digest
the domains of the toxin residing outside of the membrane. The resulting peptides were separated from the liposomes using a centrifugal filter, and two uL of this peptide solution was
spotted onto the nitrocellulose membranes (middle dot). Finally, two uL of the remaining liposome solution, containing undigested domains of LtxA, representing the domains of the toxin
that reside inside the membrane, was spotted onto the nitrocellulose membranes (bottom dot).
The membranes were allowed to dry, blocked with Blotto [39], and then incubated with one of
three monoclonal antibodies to LtxA, mAb28, mAb83, or mAb107 [14] at 4 ˚C overnight.
These antibodies recognize epitopes located throughout the sequence of LtxA (mAb28: 698–
709; mAb83: 746–757; mAb107: 926–937), as shown in Fig 1. The membranes were then incubated with goat anti-mouse-horseradish peroxidase (GAM-HRP) for one hour, and the chemiluminescence was analyzed on a Kodak Image Station. The pixel intensity of the dots was
analyzed using ImageJ, with the average background pixel intensity subtracted.

Statistical analysis
Data are presented as the mean ± standard deviation. Statistical analysis was performed using
an unpaired two-tailed student’s t-test, where p values less than 0.05 were considered to be statistically significant.

Results
LtxA interacts with the host cell membrane
Jn.9 cells express cell-surface LFA-1 and are susceptible to LtxA [26]. Confocal images of Jn.9
cells in which the membranes were stained with WGA-AF488 (green) showed evidence of
membrane localization of LtxA (LtxA-DY650, red) after a 15 min treatment (Fig 2). Five
regions of interest were selected in areas of strong LtxA fluorescence, and the Manders’ coefficient, M1, corresponding to the fraction of pixels containing LtxA that also contain WGA, was
calculated to be 0.397 ± 0.021.

LtxA adopts an altered conformation upon membrane interaction
To investigate the membrane association of LtxA, a tryptophan quenching experiment was
performed. In this assay, iodide ions quench the fluorescence of specific tryptophan residues
that are exposed to aqueous solution. Tryptophan residues that are sequestered from solution

Fig 2. LtxA associates with the plasma membrane of Jn.9 cells. Confocal images of Jn.9 cells treated with 20 nM
LtxA-DY650 (red) for 15 min show evidence of membrane localization by the toxin. The membranes were stained with
WGA-AF488 (green) and the cell nuclei with Hoescht (blue). Arrows demonstrate areas of colocalization of LtxA with
the membrane.
https://doi.org/10.1371/journal.pone.0205871.g002
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(because of protein folding or because of the protein’s association with a membrane) remain
unquenched because they are inaccessible to the aqueous iodide ions. As shown in Fig 1, LtxA
contains five Trp residues, spaced throughout the sequence, W115, W430, W478, W577, and
W901. This experiment thus allowed us to predict changes in LtxA folding as the toxin associates with the membrane environment.
Soluble LtxA and membrane-associated LtxA were exposed to increasing concentrations of
KI, and a Stern-Volmer plot was constructed from the fluorescence intensity of the Trp residues in LtxA as a function of KI concentration. The Stern-Volmer constant (KSV) was determined from the slope of the linear fit to each data set. KSV represents the rate constant of
quenching (kq) and the lifetime of unquenched Trp (τo):
KSV ¼ kq to
Thus, KSV is related to the accessibility of the Trp residues to aqueous iodide ions.
As a control, LtxA was first denatured using GuHCl. The Stern-Volmer plot of unfolded
LtxA resulted in a KSV that was calculated to be 1.00 mM-1 (Fig 3A). In this unfolded state, all
five Trp residues are accessible to the quencher; we therefore considered this KSV value to be
equivalent to a conformation in which the Trp residues are 100% accessible to quencher. We
compared all other KSV values to this to obtain the fraction accessibility of the Trp residues.
The Stern-Volmer plot of folded LtxA in solution was linear, with a slope of 0.65 mM-1, indicating that the Trp residues are approximately 60% accessible to the aqueous environment, or
that three of the five resides are exposed to solution in this folded state. When LtxA was

Fig 3. Tryptophan quenching of LtxA by KI. (A) Stern-Volmer plots, showing solvent accessibility of unfolded LtxA (black triangles), LtxA in solution (white circles),
and LtxA incubated with DMPC (grey squares). The slopes of each line represent the Stern-Volmer constant (KSV), a measure of solvent accessibility of the five Trp
residues within LtxA. (B) Stern-Volmer plots of LtxA in different membrane environments: DMPC (grey), DMPC + 40% Chol (yellow), NmDOPE (blue), and
NmDOPE + 25% CS (purple). (C) Stern-Volmer constants (KSV) of the data shown in panels (A) and (B). In unfolded LtxA, KSV is 1.0. In this unfolded state, 100% of
the Trp residues are exposed to quencher; therefore, this value corresponds to 100% accessibility of the Trp residues. When LtxA is folded, KSV decreases to 0.6,
corresponding to 60% accessibility of the residues. When LtxA is incubated with membranes, regardless of the lipid composition, KSV decreases to 0.4, indicating 40%
accessibility of the residues. � , p < 0.05; ��� , p < 0.005.
https://doi.org/10.1371/journal.pone.0205871.g003
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incubated with DMPC membranes, the slope decreased to 0.36 mM-1, indicating that two of
the five Trp residues (approximately 40%) are exposed to solution, and three residues are inaccessible to the aqueous quencher. We interpret this change to suggest that these three residues
interact with the liposome, consistent with a conformational change in LtxA as it moves from
a water-soluble to membrane-soluble state.
To determine if the membrane-associated conformation depends on lipid composition, we
repeated the quenching experiment using a variety of lipid compositions. These lipid compositions included 100% DMPC and 60% DMPC/40% Chol, a composition for which we have
demonstrated LtxA has a large affinity [24], as well as 100% NmDOPE, which LtxA is able to
disrupt, and 75% NmDOPE/25% CS, which LtxA is unable to disrupt [25]. As shown in Fig
3B, the Stern-Volmer plots of LtxA incubated with each of four different lipid compositions
are quite similar, and KSV values ranged from 0.34 to 0.44 (Fig 3C), with no statistically significant differences between the values, indicating that within these defined lipid compositions,
two of the five Trp residues are exposed to solution when LtxA is in its membrane-bound
state.

LtxA is located partially embedded in the membrane
The tryptophan quenching experiment suggested that LtxA may be partially embedded in the
membrane. To identify which domains are protected by the membrane, a trypsin digest/mass
spectrometry experiment was performed. A schematic of the experiment is shown in Fig 4A.
Briefly, LtxA was incubated with liposomes before being exposed to trypsin to digest the
domains of the toxin residing outside of the membrane. These digested peptides were separated and analyzed by MS. The remaining liposomes were collected, and the domains of LtxA
still associated with the liposomes were separated by SDS-PAGE, digested by trypsin, and analyzed by MS. The timing of the digestion was optimized, and a one-hour incubation with trypsin was determined to be sufficient to distinguish between domains located within and
external to the membrane.
Initially, free LtxA (not incubated with liposomes) was digested by trypsin and analyzed by
MS to determine the effectiveness of this technique in detecting domains throughout the entire
toxin structure. In this control experiment, peptides were detected throughout the length of
the protein, with a coverage of 84% (S2 Fig), demonstrating that MS is able to detect a majority
of the full-length protein.
To determine which portions of the toxin were solvent-exposed after liposome-association,
LtxA was incubated with DMPC liposomes and exposed to trypsin to digest only the domains
of LtxA located external to the membrane. MS analysis of the digested portion of the toxin is
shown in S3 Fig and indicates that many of the resulting peptides were derived from the
hydrophobic and C-terminal domains of LtxA, with fewer detected in the central and repeat
domains.
Next, the domain(s) of LtxA that were inaccessible to trypsin digestion, likely membrane
associated, were analyzed by MS. After trypsin digestion of the exposed domains of LtxA,
SDS-PAGE analysis of the resulting LtxA-liposome detected four primary protein bands, with
molecular weights of 70, 50, 25, and 20 kDa (Panel A in S4 Fig), which were excised and
digested with trypsin. Most of the peptides from the 70 and 50 kDa bands were located in the
central and repeat domains of LtxA, while the peptides from the 25 and 20 kDa bands were
located primarily in the central domain, as shown in Panel B in S4 Fig. Few of the detected
peptides from any of the bands were located in the hydrophobic or C-terminal domains.
Together, the MS results indicate that the hydrophobic and C-terminal domains of LtxA
are accessible to trypsin, thus likely located external to the membrane, while the central and
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Fig 4. Mass spectrometry analysis of LtxA in solution and in DMPC membranes. Mass spectrometry was used to analyze the results of a trypsin digest experiment.
(A) Schematic of the experimental design. LtxA was incubated with DMPC liposomes. The portion of the protein residing outside of the membrane was digested with
trypsin; the resulting peptides were separated from the proteoliposome and analyzed by MS. Next, the remaining liposomes, which contain only the domains of LtxA
residing inside the membrane were run on an SDS-PAGE gel (which disrupts the liposome); the major protein bands were excised, digested with trypsin and
analyzed by MS. (B) Summary of the MS results. Together, the MS results indicate that the hydrophobic and C-terminal domains of LtxA reside outside of the
membrane (black), while the central and repeat domains reside within the liposome (red). In each MS plot, the cholesterol-binding motif (yellow), acylation sites
(pink), tryptophan residues (blue), and mAb epitopes (green) are marked.
https://doi.org/10.1371/journal.pone.0205871.g004

repeat domains are protected from the trypsin and thus likely interact with the membrane (Fig
4B). This suggests that in a membrane environment, LtxA adopts a conformation in which the
N- and C-terminal ends of the molecule are located outside of the membrane while the interior
portion of the protein is located within the liposome.
To further verify our results, we took advantage of three monoclonal antibodies which recognize epitopes that are located throughout the protein [14]. The epitope of antibody mAb28
resides between residues 698–709 (central domain), the epitope of antibody 83 resides between
residues 746 and 757 (repeat domain), and the epitope of antibody 107 resides between residues 926–937 (C-terminal domain). Based on the results of the Trp quenching and MS experiments, the epitopes to mAb 28 and 83 are expected to be located within the membrane and
thus protected from the trypsin digestion, while the epitope to mAb 107 would be exposed and
subject to trypsinolysis.
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Fig 5. Dot blot analysis of exposed (external) and protected (internal) regions of LtxA in solution and in DMPC membranes. (A) Dot blot analysis of 1)
trypsin-exposed LtxA, 2) digested domains of LtxA-liposomes, and 3) undigested domains of LtxA-liposomes. (1) Full-length, digested LtxA was used as a
control (Dot #1). Antibodies 28 and 83 were able to detect their epitopes in full-length LtxA; however, the epitope for antibody 107 was digested in the typsin
treatment and therefore, undetectable. (2) LtxA was incubated with DMPC liposomes for 30 mins and then digested with trypsin. The peptides resulting from
this digestion, derived from domains of LtxA residing outside of the liposome, were separated and spotted on the nitrocellulose (Dot #2). None of the antibodies
detected their epitopes, indicating that the epitopes for mAbs 28 and 83 reside inside the membrane. The epitope of mAb 107 is not detected, indicating either it
is digested (thus, residing outside of the liposome) or is protected inside the liposome. (3) Finally, the liposomes, containing the domains of LtxA residing inside
the liposomes were spotted on the nitrocellulose (Dot #3). Antibodies 28 and 83 detected their epitopes, confirming that these two epitopes are located in a
domain of LtxA that is located inside the liposome. The epitope to mAb 107 was not detected, indicating that this epitope is not located within the membrane,
and must therefore be located outside of the membrane. (B) Quantification of dot blot intensities, determined using ImageJ. Each bar represents detection of
LtxA by one of three monoclonal antibodies, mAb 28 (black), mAb 83 (white), mAb 107 (hashed). Each intensity is normalized by the intensity of the digested
LtxA in solution dot detected by the respective antibodies.
https://doi.org/10.1371/journal.pone.0205871.g005

The trypsin digest experiment was performed as described above for MS analysis. The
resulting peptide solutions were dotted onto a nitrocellulose membrane, which was then incubated with one of the three monoclonal antibodies, as shown in Fig 5. Dot #1 was composed of
digested LtxA in solution (without liposomes). Dot #2 was composed of the peptides collected
after trypsinolysis, representing the domains of the toxin exposed to solution. Dot #3 was composed of the domains of LtxA protected from digestion, representing the domains of the toxin
that interact with the membrane. Undigested LtxA in solution and buffer controls were used
as well (data not shown) to show maximal binding of the three antibodies and absence of antibody binding, respectively.
Initially, we looked at the ability of each peptide to detect trypsin-digested LtxA. As shown
in Fig 5, although all three antibodies were able to detect undigested LtxA in solution, only
antibodies mAb 28 and mAb 83 were able to detect digested LtxA in solution; mAb 107 could
not (Dot #1). This result demonstrates that while the epitopes for mAb 28 and mAb 83 are not
affected by the trypsin digest, the epitope of mAb 107 is digested by the trypsin because of its
numerous Lys and Arg residues (S1 Table), thus preventing recognition by the antibody of this
domain after exposure to trypsin.
After incubation with DMPC liposomes and digestion of all exposed portions of LtxA by
trypsin, mAb 28 and mAb 83 recognized only the protected domains of LtxA (Dot #3) but not
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the exposed domains of LtxA (Dot #2), suggesting that the epitopes to these two antibodies are
located in the membrane-interacting domains of LtxA (central and repeat domains). Antibody
107 did not detect any LtxA in this experiment. Because the epitope of mAb 107 is susceptible
to trypsin digestion (Dot #1), we interpret this lack of antibody recognition to indicate that
this epitope is digested by trypsin, and thus located external to the membrane (C-terminal
domain). Together, the dot blot results corroborate the MS results, indicating that the C-terminal domain in which the epitope to antibody 107 is located resides external to the membrane,
while the central and repeat domains, containing the epitopes to antibodies 28 and 83, are
located within the membrane, where they are protected from trypsin digestion.

Discussion
The RTX toxins are both water- and membrane-soluble, and therefore must undergo a conformational change to sequester hydrophilic residues when in the membrane-bound state [7, 40].
Interestingly, when we previously measured conformational changes in LtxA upon movement
from the aqueous to membrane state, we found very small changes in secondary structure
[41], suggesting that the structural changes that occur during this process are localized to specific, short domains of LtxA. In addition to these small-scale, localized changes in the secondary structure, our current data indicate that the toxin’s tertiary structure may change
dramatically to accommodate the change in polarity upon binding to the membrane. These
changes appear to be independent of lipid-composition and occur in the absence of LFA-1.
In these studies, we have used three assays of aqueous accessibility to identify the domains
of LtxA that are exposed to solvent and thus reside outside of the plasma membrane. The tryptophan quenching experiments indicated that in the membrane-bound conformation, two of
the five Trp residues of LtxA are exposed to the aqueous environment. This finding is consistent with the trypsin digest/MS experiment, which demonstrated that the hydrophobic domain
and C-terminal domain, each of which contains one Trp residue, are exposed to the aqueous
environment when the toxin is incubated with DMPC liposomes. Additionally, the epitopes to
two monoclonal anti-LtxA antibodies, located in the central and repeat domains, were found
to be protected from trypsinolysis, while the epitope to a third monoclonal antibody located in
the C-terminal domain was exposed to aqueous trypsin. Collectively, these three experiments
suggest that LtxA associates with the membrane in a conformation in which the hydrophobic
and C-terminal domains reside outside of the membrane and the central and repeat domains
inside (Fig 6). Similar results were obtained in liposomes with four distinct lipid compositions,
indicating that the conformation may be insensitive to the presence of cholesterol or nonlamellar phase-forming lipids.
The specific transmembrane (TM) domains of the membrane-embedded conformation of
LtxA most likely reside between the hydrophobic and central domains and between the repeat
and C-terminal domains. One clue to the identity of the N-terminal transmembrane domain
comes from the MS analysis of the full-length, soluble LtxA. Transmembrane domains often
do not contain sites for protease digestion [42] and are helical in nature [43]. In our MS analysis, we identified a long undigested domain between residues 368 and 412, which contains
hydrophobic residues, including a number of alanine residues, which promote helix formation
[44, 45]. Because this domain is located between the predicted external hydrophobic domain
and the predicted internal central domain, it is quite likely that one of the two TM domains is
found within this region.
One common structural feature of the RTX toxins is an N-terminal domain that contains a
large number of hydrophobic residues; this domain has been hypothesized to play a role in the
binding of the toxins to the lipid bilayer [2]. Here, we have found that the hydrophobic domain
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Fig 6. Location of LtxA in membrane. Together, the results indicate that LtxA adopts a U-shaped conformation, with the
hydrophobic and C-terminal domains residing outside of the membrane. The MS results indicate that the hydrophobic and Cterminal domains reside external to the membrane, while the central and repeat domains reside inside the membrane. This
finding was confirmed by dot blot analysis using three monoclonal antibodies, which demonstrated that the epitopes for mAb
28 and 83 reside inside the membrane and the epitope for mAb 107 resides outside of the membrane. The tryptophan
quenching experiment indicated that two of the five tryptophan residues reside external to the membrane; based on the MS
results, these residues are W115 and W901, located in the hydrophobic and C-terminal domains, respectively. W430, W478, and
W577, located in the central domain are located inside the liposome. The figure also shows the subunits of LFA-1 (αL, purple;
β2, green) to demonstrate which domains of LtxA may interact with the extracellular and intracellular domains of LFA-1.
https://doi.org/10.1371/journal.pone.0205871.g006

of LtxA, however, resides external to the membrane and is therefore likely not involved in
the reported membrane interactions of the toxin. This finding agrees with a previous report
that the binding of α-HlyA to lipid bilayers is not regulated by the hydrophobic domain [46].
Previously, we found that a cholesterol recognition amino acid consensus (CRAC) motif is
present within the hydrophobic domain and is essential for LtxA binding to cholesterol on
the host cell plasma membrane and toxicity [24]. In the present work, this CRAC site was
detected in both the intra- and extra-membrane peptides by MS, indicating that this site may
be located very close to the membrane interface, consistent with a mechanism suggested by
recent work in our lab [47, 48], demonstrating that LtxA recognizes cholesterol near the membrane interface.
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In addition to cholesterol, LtxA must also recognize an integrin receptor, LFA-1, on the target cell membrane [26]. We have found that LtxA is able to interact with cell membranes that
do not express LFA-1, but is unable to enter the cellular cytosol in the absence of this integrin
receptor. The domains of LFA-1 that LtxA has been reported to interact with include the βpropeller of the αL subunit [32, 33] and the I-EGF domains of the β2 subunit [34] as well as the
cytosolic domains of both the αL and β2 subunits [35]. The membrane-bound conformation
suggested by our proteolysis studies suggests that LtxA may be able to simultaneously interact
with cholesterol as well as the extra- and intracellular domains of LFA-1. We hypothesize that
the toxin first inserts into the membrane to adopt the conformation described here; this structure facilitates binding to LFA-1. Previous work in our lab identified three monoclonal antibodies (mAb 28, mAb 83, and mAb 107) that inhibit LtxA-mediated cytotoxicity in HL-60
cells [14]. The epitopes recognized by mAb 83 (residues 746–757) and 107 (residues 926–937)
were predicted to be involved in the recognition of LFA-1 by LtxA. We have shown here that
the epitope recognized by mAb 83 is protected from trypsin digestion by the liposome, suggesting that it may interact with the cytosolic domains of LFA-1, while the epitope recognized
by mAb 107 is digested by trypsin, suggesting it is located external to the membrane and may
therefore interact with the extracellular domains of LFA-1, as shown in Fig 6.
In the predicted conformation, the two acylation sites of LtxA are located in a domain of
the toxin that is located within the liposome. Consensus on the role of acylation in RTX toxins
has not been reached, but it appears to play a role in membrane interactions, including cell
association and lysis, more so than in toxin-receptor interactions [49–53]. In addition, the
third monoclonal antibody epitope, recognized by mAb 28 (residues 698–709), which was
shown to be involved in membrane, but not LFA-1, interactions [14], is located in this same
region, in the putative membrane-interacting domain. While the specific role of these hydrocarbon chains on LtxA activity has not yet been identified, our results suggest that the acyl
chains serve to initially anchor the protein to the membrane to initiate the membrane destabilization and conformational change observed here.

Conclusions
We have presented evidence of a membrane-inserted conformation of LtxA that is consistent
with previous reports of LtxA and RTX membrane interactions. Based on the structural and
sequence similarities in this family of proteins, we predict that many of the RTX toxins may
adopt a similar conformation in the membrane environment. Because this conformation is
independent of lipid composition, we hypothesize that the interaction of the RTX toxins with
their specific receptors determines the cell type specificity of the interaction, but that the membrane interaction is mostly consistent across the family.

Supporting information
S1 Fig. LtxA purification. LtxA was purified by ion-exchange chromatography, and the purity
was analyzed by SDS-PAGE.
(TIF)
S2 Fig. MS detection of full-length LtxA in solution. LtxA in solution was digested with trypsin, and the resulting peptides were analyzed by MS. Peptides across the entire sequence of
LtxA were detected, with a coverage of 84%. In the plot, the cholesterol-binding motif (yellow),
acylation sites (pink), tryptophan residues (blue), and mAb epitopes (green) are marked.
(TIF)
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S3 Fig. MS detection of peptides residing outside the DMPC liposome. LtxA was incubated
with DMPC liposomes and then exposed to trypsin, resulting in digestion of only the domains
of LtxA residing outside of the liposome. These peptides were separated and analyzed by MS.
Most of the external peptides detected by MS were located in the hydrophobic and C-terminal
domains. In the plot, the cholesterol-binding motif (yellow), acylation sites (pink), tryptophan
residues (blue), and mAb epitopes (green) are marked.
(TIF)
S4 Fig. MS detection of peptides residing within the DMPC liposome. After trypsin-digestion of the external peptides of LtxA, the remaining proteoliposomes containing only the
domains of LtxA protected from digestion by the liposome were run on an SDS-PAGE gel (A).
Four major bands at 1) 70 kDa, 2) 50 kDa, 3) 25 kDa, and 4) 20 kDa were excised and digested
by trypsin. (B) The peptides from the four major bands in the SDS-PAGE gel were analyzed by
MS. In the 70- and 50-kDa bands, the detected peptides resided in the central and repeat
domains, and in the 25- and 20-kDa bands, the detected peptides resided in the repeat domain.
In each plot, the cholesterol-binding motif (yellow), acylation sites (pink), tryptophan residues
(blue), and mAb epitopes (green) are marked.
(TIF)
S1 Table. mAb epitopes and trypsin digest sites. Trypsin digest sites are in bold and underlined.
(DOCX)
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Hsin-Yao Tang, Margaret E. Duszyk.
Methodology: Angela C. Brown, Kathleen Boesze-Battaglia, Kaye Speicher, Edward T. Lally.
Supervision: Kathleen Boesze-Battaglia, Edward T. Lally.
Writing – original draft: Angela C. Brown, Nataliya V. Balashova, Hsin-Yao Tang, Edward T.
Lally.
Writing – review & editing: Kathleen Boesze-Battaglia.

References
1.

Taichman NS, Simpson DL, Sakurada S, Cranfield M, DiRienzo J, Slots J. Comparative studies on the
biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microbiol Immunol. 1987;
2(3):97–104. PMID: 3507626

2.

Welch RA. Pore-forming cytolysins of gram-negative bacteria. Molecular Microbiology. 1991; 5:521–8.
PMID: 2046545

PLOS ONE | https://doi.org/10.1371/journal.pone.0205871 October 18, 2018

14 / 17

Membrane localization of LtxA

3.

Tsai CC, McArthur WP, Baehni PC, Hammond BF, Taichman NS. Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism. Infect Immun. 1979; 25
(1):427–39. PMID: 113347

4.

Baehni P, Tsai CC, McArthur WP, Hammond BF, Taichman NS. Interaction of inflammatory cells and
oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism. Infect Immun. 1979; 24(1):233–43. PMID: 222679

5.

Baehni PC, Tsai CC, McArthur WP, Hammond BF, Shenker BJ, Taichman NS. Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol. 1981; 26(8):671–6. PMID: 6172101

6.

Lally ET, Golub EE, Kieba IR, Taichman NS, Rosenbloom J, Rosenbloom JC, et al. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to
homologous toxins. Journal of Biological Chemistry. 1989; 264(26):15451–6. PMID: 2670940

7.

Lally ET, Hill RB, Kieba IR, Korostoff J. The interaction between RTX toxins and target cells. Trends in
Microbiology. 1999; 7(9):356–61. https://doi.org/10.1016/S0966-842X(99)01530-9 PMID: 10470043

8.

Fong KP, Tang HY, Brown AC, Kieba IR, Speicher DW, Boesze-Battaglia K, et al. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or
hydroxylated fatty acyl chains. Molecular Oral Microbiology. 2011; 26(4):262–76. https://doi.org/10.
1111/j.2041-1014.2011.00617.x PMID: 21729247

9.

Bauche C, Chenal A, Knapp O, Bodenreider C, BENZ R, Chaffotte A, et al. Structural and Functional
Characterization of an Essential RTX Subdomain of Bordetella pertussis Adenylate Cyclase Toxin.
Journal of Biological Chemistry. 2006; 281(25):16914–26. https://doi.org/10.1074/jbc.M601594200
PMID: 16627468

10.

Baumann U, Wu S, Flaherty KM, McKay DB. Three-dimensional structure of the alkaline protease of
Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO
J. 1993; 12(9):3357–64. PMID: 8253063

11.

Lilie H, Haehnel W, Rudolph R, Baumann U. Folding of a synthetic parallel β-roll protein. FEBS Letters.
2000; 470(2):173–7. PMID: 10734229

12.

Perez ACS, Karst JC, Davi M, Guijarro JI, Ladant D, Chenal A. Characterization of the Regions Involved
in the Calcium-Induced Folding of the Intrinsically Disordered RTX Motifs from the Bordetella pertussis
Adenylate Cyclase Toxin. Journal of Molecular Biology. 2010; 397(2):534–49. https://doi.org/10.1016/j.
jmb.2010.01.031 PMID: 20096704

13.

Jarchau T, Chakraborty T, Garcia F, Goebel W. Selection for transport competence of C-terminal polypeptides derived from Escherichia coli hemolysin: the shortest peptide capable of autonomous HIyB/
HIyD-dependent secretion comprises the C-terminal 62 amino acids of HlyA. Molecular and General
Genetics MGG. 245: Springer-Verlag; 1994. p. 53–60. PMID: 7531275

14.

Lally ET, Golub EE, Kieba IR. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. Journal of Biological Chemistry. 1994; 269(49):31289–95. PMID: 7983074

15.

Kanonenberg K, Schwarz CKW, Schmitt L. Type I secretion systems—a story of appendices. Research
in Microbiology Bacterial secretion systems: function and structural biology. 1642013. p. 596–604.

16.

Delepelaire P. Type I secretion in gram-negative bacteria. Biochimica et Biophysica Acta (BBA)—
Molecular Cell Research. 2004; 1694(1):149–61.

17.

Holland IB, Schmitt L, Young J. Type 1 protein secretion in bacteria, the ABC-transporter dependent
pathway (Review). Molecular Membrane Biology. 2005; 22(1–2):29–39. https://doi.org/10.1080/
09687860500042013 PMID: 16092522

18.

Chenal A, Guijarro JI, Raynal B, Delepierre M, Ladant D. RTX Calcium Binding Motifs Are Intrinsically
Disordered in the Absence of Calcium: IMPLICATION FOR PROTEIN SECRETION. Journal of Biological Chemistry. 2009; 284(3):1781–9. https://doi.org/10.1074/jbc.M807312200 PMID: 19015266

19.

Gangola P, Rosen BP. Maintenance of intracellular calcium in Escherichia coli. Journal of Biological
Chemistry. 1987; 262(26):12570–4. PMID: 2442165

20.
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